Lipidic Aminoglycoside Derivatives: A New Class of Immunomodulators Inducing a Potent Innate Immune Stimulation
Abstract Development of simple and fully characterized immunomodulatory molecules is an active area of research to enhance current immunotherapies. Monophosphoryl lipid A (MPL), a nontoxic lipidic derivative from bacteria, is the first and currently only adjuvant approved in humans. However, its cap...
Main Authors: | Thibault Colombani, Thomas Haudebourg, Marion Decossas, Olivier Lambert, Grace Ada Da Silva, Frederic Altare, Bruno Pitard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.201900288 |
Similar Items
-
Molecular Mechanisms Underlying Phosphatidylinositol-Specific Phospholipase C Mediated Regulation Of Lipid Metabolism
by: Rupwate, Sunny Dinkar
Published: (2016) -
I. Understanding Membrane Interactions of Bacterial Exoproteins; II. Identification and Characterization of a Novel Mammalian cis-Aconitate Decarboxylase
by: Cheng, Jiongjia
Published: (2013) -
Development of Novel, Potent Phosphatidyl–Choline-Specific Phospholipase C Inhibitors
by: Lisa I. Pilkington, et al.
Published: (2019-08-01) -
Phosphoinositide-Dependent Signaling in Cancer: A Focus on Phospholipase C Isozymes
by: Eric Owusu Obeng, et al.
Published: (2020-04-01) -
Understanding the kinetic profile of phosphatidylinositol-specific phospholipase C from Listeria monocytogenes
by: Chen, Wei
Published: (2008)